UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Liver international, ISSN 1478-3223, 09/2015, Volume 35, Issue 9, pp. 2155 - 2166
epidemiology | risk factors | treatment patterns | liver cancer | disease management | global trends | observational study | Liver cancer | Observational study | Global trends | Disease management | Treatment patterns | Epidemiology | Risk factors | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Carcinoma, Hepatocellular - mortality | Humans | Middle Aged | Ethanol - administration & dosage | Catheter Ablation | Male | Liver Neoplasms - therapy | Embolization, Therapeutic | Liver Neoplasms - mortality | Hepatitis B - complications | Adult | Female | Hepatitis C - complications | Retrospective Studies | Liver Neoplasms - virology | Risk Factors | Europe - epidemiology | Carcinoma, Hepatocellular - virology | Asia - epidemiology | Survival Analysis | Aged | Carcinoma, Hepatocellular - therapy | Disease Management | North America - epidemiology | Longitudinal Studies | Ablation (Surgery) | Carcinoma | Liver | Hepatitis C virus | Hepatitis C | Health aspects | Cancer | Index Medicus | Liver Cancer
Journal Article
Hepatology (Baltimore, Md.), ISSN 0270-9139, 08/2015, Volume 62, Issue 2, pp. 440 - 451
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Multivariate Analysis | Carcinoma, Hepatocellular - mortality | Confidence Intervals | Follow-Up Studies | United States | Humans | Middle Aged | Male | Hepatectomy - mortality | Liver Neoplasms - mortality | Neoplasm Recurrence, Local - mortality | Patient Selection | Neoplasm Recurrence, Local - pathology | Neoplasm Invasiveness - pathology | Statistics, Nonparametric | Adult | Female | Retrospective Studies | Hepatectomy - methods | Risk Assessment | Carcinoma, Hepatocellular - diagnosis | Proportional Hazards Models | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Treatment Outcome | Disease-Free Survival | Liver Neoplasms - diagnosis | Survival Analysis | Aged | Neoplasm Staging | Cohort Studies | Hypertension | Liver cancer | Multivariate analysis | Liver cirrhosis | Mortality | Index Medicus
Journal Article
Clinical and molecular hepatology, ISSN 2287-2728, 03/2018, Volume 24, Issue 1, pp. 1 - 9
Liver cancer | Hepatocellular carcinoma | Prevalence | Epidemiology | Incidence | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Carcinoma, Hepatocellular - epidemiology | Carcinoma, Hepatocellular - mortality | Age Factors | Carcinoma, Hepatocellular - diagnosis | Humans | Survival Rate | Liver Neoplasms - mortality | Hepatitis - complications | Liver Neoplasms - epidemiology | Hepatitis - diagnosis | Liver Neoplasms - diagnosis | Republic of Korea - epidemiology | Index Medicus | Review | 내과학
Journal Article
Journal of hepatology, ISSN 0168-8278, 2014, Volume 60, Issue 6, pp. 1268 - 1289
Gastroenterology and Hepatology | Practice guidelines | Diagnosis and management | Intrahepatic cholangiocarcinoma | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Evidence-Based Medicine - standards | Bile Duct Neoplasms - diagnosis | Bile Duct Neoplasms - epidemiology | Bile Duct Neoplasms - therapy | Cholangiocarcinoma - therapy | Cholangiocarcinoma - diagnosis | Global Health | Gastroenterology - standards | Cholangiocarcinoma - epidemiology | Humans | Bile Ducts, Intrahepatic | Practice Guidelines as Topic | Practice guidelines (Medicine) | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 03/2018, Volume 391, Issue 10126, pp. 1163 - 1173
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Niacinamide - analogs & derivatives | Carcinoma, Hepatocellular - mortality | Humans | Middle Aged | Liver Neoplasms - drug therapy | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Male | Survival Rate | Treatment Outcome | Antineoplastic Agents - therapeutic use | Liver Neoplasms - mortality | Carcinoma, Hepatocellular - drug therapy | Sorafenib | Female | Aged | Quinolines - therapeutic use | Disease | Liver | Clinical trials | Hepatocellular carcinoma | Cancer therapies | Disease control | Survival | Evidence-based medicine | Studies | Liver cancer | Chemotherapy | Hepatology | Questionnaires | Response rates | Fatalities | Drug dosages | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 07/2018, Volume 379, Issue 1, pp. 54 - 63
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Anilides - therapeutic use | Double-Blind Method | Anilides - adverse effects | Humans | Middle Aged | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Male | Antineoplastic Agents - therapeutic use | Disease-Free Survival | Pyridines - adverse effects | Carcinoma, Hepatocellular - drug therapy | Antineoplastic Agents - adverse effects | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Aged | Pyridines - therapeutic use | Tyrosine | Diarrhea | Hepatocellular carcinoma | Fatigue | Oncology | Growth factor receptors | Patients | Cancer therapies | Survival | Vascular endothelial growth factor receptors | Axl protein | Liver cancer | Hepatitis | Hospitals | Collaboration | Medical prognosis | Aspartate aminotransferase | Vascular endothelial growth factor | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 10/2013, Volume 31, Issue 28, pp. 3517 - 3524
Niacinamide - analogs & derivatives | Carcinoma, Hepatocellular - mortality | Alanine - therapeutic use | Prognosis | Follow-Up Studies | Triazines - therapeutic use | Humans | Middle Aged | Male | Liver Neoplasms - mortality | Young Adult | Alanine - analogs & derivatives | Carcinoma, Hepatocellular - drug therapy | Aged, 80 and over | Adult | Female | Liver Neoplasms - pathology | Double-Blind Method | Liver Neoplasms - drug therapy | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Survival Rate | Protein Kinase Inhibitors - therapeutic use | Carcinoma, Hepatocellular - pathology | Aged | Neoplasm Staging | Index Medicus
Journal Article
Journal of hepatology, ISSN 0168-8278, 2017, Volume 66, Issue 6, pp. 1166 - 1172
Gastroenterology and Hepatology | Carcinoma, hepatocellular | Liver cancer | Response evaluation criteria in solid tumours | Objective response | Brivanib, mRECIST | Advanced BCLC | Surrogate end-point | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Carcinoma, Hepatocellular - mortality | Alanine - therapeutic use | Prognosis | Double-Blind Method | Triazines - therapeutic use | Humans | Middle Aged | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Male | Antineoplastic Agents - therapeutic use | Liver Neoplasms - mortality | Young Adult | Alanine - analogs & derivatives | Carcinoma, Hepatocellular - drug therapy | Carcinoma, Hepatocellular - pathology | Aged, 80 and over | Biomarkers | Adult | Female | Liver Neoplasms - pathology | Aged | Hepatocellular carcinoma | Solid tumors | Medical diagnosis | Survival | Patients | Tumors | Index Medicus | Assaigs clínics | Clinical trials | Càncer de fetge | Pronòstic mèdic | Life Sciences | Human health and pathology | Hépatology and Gastroenterology
Journal Article